11 November 2015 : Clinical Research
High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification
Xiao FuABCDEF, Qin-Qin CuiBCD, Jian-Ping NingABCDFG, Shuang-Shuang FuB, Xiao-Hua LiaoBDOI: 10.12659/MSM.894894
Med Sci Monit 2015; 21:3467-3473
Abstract
BACKGROUND: High- and low-flux hemodialysis (HFHD and LFHD, respectively) are dialysis procedures designed to eliminate blood toxins that accumulate in end-stage renal disease. HFHD may reduce vascular calcification by removing serum fibroblast growth factor 23 (FGF-23). However, whether HFHD is better than LFHD is still under debate. We therefore compared the efficacy of HFHD and LFHD in controlling FGF-23 and vascular calcification.
MATERIAL AND METHODS: Fifty hemodialysis patients were recruited and randomly treated with either HFHD or LFHD. Fasting venous blood was collected at baseline, six months, and twelve months after the treatment. We then measured levels of FGF-23, calcium, phosphorus, parathyroid hormone, and alkaline phosphatase. Further, abdominal lateral radiographs were taken to calculate aorta abdominalis calcification scores (AACs).
RESULTS: Compared to the LFHD group, FGF-23 and AACs in the HFHD group significantly decreased after 12 months treatment (p=0.049 and p=0.002, respectively). AACs were positively correlated with FGF-23 in all patients (p=0.004), the HFHD group alone (p=0.040), and the LFHD group alone (p=0.037). We also found that older patients, patients with higher blood phosphorus levels, and higher FGF-23 levels had an increased risk of aorta abdominalis calcification (p=0.048, p=0.003, p=0.001, respectively). HFHD was more able to reduce the risk of aorta abdominalis calcification than LFHD (p=0.003).
CONCLUSIONS: FGF-23 is an independent risk factor for the development of vascular calcification. HFHD may benefit hemodialysis patients by reducing serum FGF-23 levels and controlling vascular calcification.
Keywords: Alkaline Phosphatase - metabolism, Aorta, Abdominal - pathology, Calcium - blood, Fibroblast Growth Factors - blood, Gene Expression Regulation, Kidney Failure, Chronic - therapy, Parathyroid Hormone - blood, Phosphorus - blood, Radiography, Abdominal, Regression Analysis, Renal Dialysis, Renal Insufficiency, Chronic - therapy, Risk Factors, Vascular Calcification - blood
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Animal Research
Role of the Dorsal Cortex of the Inferior Colliculus in the Precedence EffectMed Sci Monit In Press; DOI: 10.12659/MSM.945605
Laboratory Research
Comparative Evaluation of the Dimensional Accuracy of Silicone-Based Putty Reline Impressions with Differen...Med Sci Monit In Press; DOI: 10.12659/MSM.946537
Clinical Research
Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Oc...Med Sci Monit In Press; DOI: 10.12659/MSM.945937
Review article
COL3A1 Gene Polymorphism and Its Impact on Female Pelvic Organ ProlapseMed Sci Monit In Press; DOI: 10.12659/MSM.946367
Most Viewed Current Articles
17 Jan 2024 : Review article 6,962,174
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 699,683
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 22,873
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 17,628
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912